Our thanks to Prof Richard Scolyer AO
Prof Richard Scolyer AO has announced that he has decided to step down from his role as Co-Medical Director of Melanoma Institute Australia. Richard has been in this role since January 2017.
Dr Alina Mueller
Alina Mueller is a clinician scientist at the Department of Dermatology at the University Hospital Basel, Switzerland, specialising in Dermato-Oncology. Read about her four-week Medical Oncology observership at MIA!
Dr Marie Brinch-Møller Weitemeyer
Marie Brinch-Møller Weitemeyer has recently completed a four-week surgical observership at Melanoma Institute Australia as part of her PhD program. Learn about her experience!
Dr Andrea Boutros
Dr Andrea Boutros is a Medical Oncology Fellow at Melanoma Institute Australia. Read his Q&A to learn of his inspiring future career goals, his impressive current work, and his surprising hidden talent!
Outstanding efforts by Community Fundraisers all over Australia
From zumba events to kilt runs and motorcycle rides, read more about the Australia-wide efforts of our passionate community fundraisers, and their supporters, all contributing to not only support our life-saving research, but also raise awareness about melanoma and its prevention.
Living with melanoma during the festive season
For people living with melanoma and their loved ones, the holiday period can bring up mixed experiences and feelings. We’ve put together a fact sheet of tips for patients, and for family and friends, which we hope will help make the most of this time.
MIA’s ground-breaking work recognised with two Cancer NSW Awards
We are proud to announce that the ground-breaking work of the MIA team has been recognised with two prestigious 2024 NSW Premier’s Awards for Outstanding Cancer Research.
Dr Tuba Nur Gide
Get to know Dr Tuba Nur Gide in and out of the lab as she answers our questions and gives us a glimpse into her work on developing predictive tools to allow personalised immunotherapy treatment for melanoma.
Be part of research study on genetic information and testing
Patients, and families of patients, impacted by advanced melanoma are invited to participate in an online interview to explore their views, experiences, and needs related to genetic information, support and testing.
Together, Amplifying Impact at #AMC2024
Hosted by MIA in Sydney, AMC2024 brought together 776 multidisciplinary delegates to engage in insightful discussions, presentations and workshops, all dedicated to reaching our common goal of zero deaths from melanoma. See our AMC2024 photo album.